Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 2Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 6Neoplasms 3Neoplasm Metastasis 2Cancer Pain 2Breast Neoplasms 2Wounds and Injuries 1Pleural Effusion, Malignant 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Leiomyoma 1Ileus 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Ropivacaine 2Magnesium Sulfate 2Fentanyl 2trimebutine 3-thiocarbamoylbenzenesulfonate 1ramosetron 1Transdermal Patch 1Tablets 1Surveys and Questionnaires 1Psilocybin 1Pregabalin 1Nefopam 1Morphine 1Lidocaine 1Levobupivacaine 1Ketoprofen 1Ketamine 1Injections, Subcutaneous 1High-Energy Shock Waves 1Control Groups 1Capsaicin 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthetics, Local 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Morphine × Clear all
NCT04243954 2021-03-05

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Fujian Cancer Hospital

Phase 2 Completed
95 enrolled

Cancer Pain, Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡